Viltolarsen: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 April 2025

  • curprev 18:3818:38, 30 April 2025 Alara E. Dagsali talk contribs 16,108 bytes +16,108 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=viltolarsen |aOrAn=a |drugClass=exon 53 of the dystrophin pre-mRNA |indicationType=treatment |indication=Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. This indication is approved under accelerated approval based on an increase in dystrophin production in skeletal muscle observed in patients treated..."
Retrieved from "https://www.wikidoc.org/index.php/Viltolarsen"